Mankind Pharma

Please find attached intimation of closure of trading window

25 Sep, 2025 | 06:05pm • Source: BSE

Please find attached intimation of participation in Investor Conference by management of the Company

15 Sep, 2025 | 05:01pm • Source: BSE

Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

10 Sep, 2025 | 10:33pm • Source: BSE

Please find attached intimation of participation in Investor Conference by management of the Company

09 Sep, 2025 | 12:26pm • Source: BSE

Please find attached intimation of receipt of approval for reclassification of Ayushi and Poonam Estates LLP from "Promoter & Promoter Group" to "Public" Category

02 Sep, 2025 | 06:08pm • Source: BSE

Please find attached intimation of participation in Investor Conference

27 Aug, 2025 | 03:38pm • Source: BSE

Allotment of 29,742 Equity Shares under Mankind Employee Stock Option Plan 2022

26 Aug, 2025 | 02:34pm • Source: BSE

Please find attached intimation of participation in Investor Conference

25 Aug, 2025 | 05:41pm • Source: BSE

Please find attached intimation regarding incorporation of a wholly owned subsidiary in Russia

19 Aug, 2025 | 03:14pm • Source: BSE

Intimation about the upcoming Investor Meet of Mankind Pharma Limited

11 Aug, 2025 | 05:27pm • Source: BSE

We wish to inform you that the shareholders of the Company, at the 34th Annual General Meeting held on Thursday August 7, 2025 has considered...

08 Aug, 2025 | 05:46pm • Source: BSE

Please find enclosed herewith voting results and Scrutinizers Report pertaining to 34th Annual General Meeting of the Company held on August 7, 2025.

08 Aug, 2025 | 04:43pm • Source: BSE

Please find enclosed herewith proceedings of the 34th Annual General Meeting of the Company held on August 7, 2025 through Video Conferencing.

07 Aug, 2025 | 05:39pm • Source: BSE

Please find enclosed herewith transcript of the Investor Conference Call for Q1 FY26 held on August 1, 2025

06 Aug, 2025 | 11:20pm • Source: BSE

Please find attached Newspaper Publication of unaudited financial results for the quarter ended on June 30, 2025

01 Aug, 2025 | 05:03pm • Source: BSE

Investor Conference Call for Q1 & FY26 - Audio Recording

01 Aug, 2025 | 03:06pm • Source: BSE

Please find attached the Specimen of the Communication sent to the shareholders regarding the deduction of tax to be deducted on the Interim Dividend declared...

31 Jul, 2025 | 09:56pm • Source: BSE

Please find attached Monitoring Agency Report as issued by Care Ratings Limited for the quarter ended on June 30, 2025

31 Jul, 2025 | 06:54pm • Source: BSE

Dr. Sanjay Koul has tendered his resignation from the position of Chief Marketing Officer of the Company w.e.f. August 1, 2025. Further, Mr. Koul will...

31 Jul, 2025 | 06:39pm • Source: BSE

Board of Directors of the Company in its meeting held on July 31, 2025 has considered and approved the acquisition of Branded Generic Business relating...

31 Jul, 2025 | 06:27pm • Source: BSE